Skip to main content

Table 1 Clinical features of human endometrial cancer

From: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

  Total Low-risk High-risk Recurrence
n (%) 34 (100) 7 (21) 27 (79) 7 (21)
Age, mean (range) 59 (38–78) 58 (38–75) 60 (45–78) 56 (45–67)
FIGO stage, n (%)     
I 15 (44) 7 (100) 8 (30) 1 (14)
II 3 (9) 0 (0) 3 (11) 1 (14)
III 14 (41) 0 (0) 14 (52) 3 (43)
IV 2 (6) 0 (0) 2 (7) 2 (29)
Grade, n (%)     
1 15 (44) 5 (71) 10 (37) 0 (0)
2 13 (38) 2 (29) 11 (41) 6 (86)
3 6 (18) 0 (0) 6 (22) 1 (14)
Lymphovascular space invasion, n (%)     
+ 10 (29) 0 (0) 10 (37) 2 (29)
- 24 (71) 7 (100) 17 (63) 5 (71)
MIR31, mean 18.40 2.05 21.90 9.15
(range) (0.15 - 284.06) (0.33 - 5.98) (0.15 - 284.06) (0.70 - 27.77)